{"pmid":32213329,"title":"Scientific and ethical basis for social-distancing interventions against COVID-19.","text":["Scientific and ethical basis for social-distancing interventions against COVID-19.","Lancet Infect Dis","Lewnard, Joseph A","Lo, Nathan C","32213329"],"journal":"Lancet Infect Dis","authors":["Lewnard, Joseph A","Lo, Nathan C"],"date":"2020-03-28T11:00:00Z","year":2020,"_id":"32213329","week":"202013|Mar 23 - Mar 29","doi":"10.1016/S1473-3099(20)30190-0","source":"PubMed","topics":["Prevention"],"weight":1,"_version_":1662445896440217600,"score":7.208847,"similar":[{"pmid":32170898,"title":"COVID-19 and Rationally Layered Social Distancing.","text":["COVID-19 and Rationally Layered Social Distancing.","I would like to thank Dr. Thomson for the very pertinent and relevant points that he raised in his thoughtful letter Where are we now with COVID-19? [1]. As my response will illustrate, and in what probably will become a defining feature of conversations surrounding COVID-19 for quite some time, attempts to answer will only make room for more questions. As COVID-19 is unfolding, every day is marked by novel developments. Since the editorial went to press [2], the outbreak has expanded considerably. Over 128,000 individuals were infected worldwide as of March 13, 2020, leading to 4720 deaths [3]. In early March, while the outbreak in China appeared to start to subside [4], it started to amplify in Europe and the United States. The first fatality in the United States occurred on February 29, 2020 in a suburb of Seattle. On March 4m the first death was reported outside WA state, in CA, and was the 11(th) death in the United States. On March 6, the first two fatalities were reported in Florida. On March 11, 2020, the World Health Organization declared the outbreak a pandemic [5].","Int J Clin Pract","Stein, Richard","32170898"],"abstract":["I would like to thank Dr. Thomson for the very pertinent and relevant points that he raised in his thoughtful letter Where are we now with COVID-19? [1]. As my response will illustrate, and in what probably will become a defining feature of conversations surrounding COVID-19 for quite some time, attempts to answer will only make room for more questions. As COVID-19 is unfolding, every day is marked by novel developments. Since the editorial went to press [2], the outbreak has expanded considerably. Over 128,000 individuals were infected worldwide as of March 13, 2020, leading to 4720 deaths [3]. In early March, while the outbreak in China appeared to start to subside [4], it started to amplify in Europe and the United States. The first fatality in the United States occurred on February 29, 2020 in a suburb of Seattle. On March 4m the first death was reported outside WA state, in CA, and was the 11(th) death in the United States. On March 6, the first two fatalities were reported in Florida. On March 11, 2020, the World Health Organization declared the outbreak a pandemic [5]."],"journal":"Int J Clin Pract","authors":["Stein, Richard"],"date":"2020-03-15T11:00:00Z","year":2020,"_id":"32170898","week":"202011|Mar 09 - Mar 15","doi":"10.1111/ijcp.13501","source":"PubMed","locations":["China","Florida","Seattle","United States"],"countries":["China","United States"],"countries_codes":["CHN|China","USA|United States"],"topics":["Mechanism","Prevention"],"weight":1,"_version_":1662334543688892418,"score":58.5404},{"pmid":32187421,"title":"COVID-19: social distancing, ACE 2 receptors, protease inhibitors and beyond?","text":["COVID-19: social distancing, ACE 2 receptors, protease inhibitors and beyond?","I am most grateful to Dr Stein for his thoughtful and considered response to my recent letter((1)) . However, completely as he predicted, his answers only raised more questions. I was struck by the analysis of the known mortality data from COVID-19. It is interesting that for a respiratory pathogen, risk of mortality seems to be lower for those with underlying respiratory disease than with pre-existing cardiac pathology.","Int J Clin Pract","Thomson, George","32187421"],"abstract":["I am most grateful to Dr Stein for his thoughtful and considered response to my recent letter((1)) . However, completely as he predicted, his answers only raised more questions. I was struck by the analysis of the known mortality data from COVID-19. It is interesting that for a respiratory pathogen, risk of mortality seems to be lower for those with underlying respiratory disease than with pre-existing cardiac pathology."],"journal":"Int J Clin Pract","authors":["Thomson, George"],"date":"2020-03-19T11:00:00Z","year":2020,"_id":"32187421","week":"202012|Mar 16 - Mar 22","doi":"10.1111/ijcp.13503","source":"PubMed","weight":0,"_version_":1662334543497003008,"score":46.745255},{"pmid":32218525,"title":"COVID-19: Biomedical research in a world under social-distancing measures.","text":["COVID-19: Biomedical research in a world under social-distancing measures.","Nat Med","Arnold, Carrie","32218525"],"journal":"Nat Med","authors":["Arnold, Carrie"],"date":"2020-03-29T11:00:00Z","year":2020,"_id":"32218525","week":"202013|Mar 23 - Mar 29","doi":"10.1038/d41591-020-00005-1","source":"PubMed","topics":["General Info"],"weight":1,"_version_":1662540582119014400,"score":46.745255},{"pmid":32213700,"title":"Italy in a Time of Emergency and Scarce Resources: The Need for Embedding Ethical Reflection in Social and Clinical Settings.","text":["Italy in a Time of Emergency and Scarce Resources: The Need for Embedding Ethical Reflection in Social and Clinical Settings.","The COVID-19 virus is severely testing the Italian healthcare system, as the requests for intensive treatment are greater than the real capacity of the system to receive patients. Given this emergency situation, it follows that citizens are limited in their freedom of movement in order to limit infection, and that in hospitals a significant number of critical situations must be faced. This brief contribution aims to offer a reflection on the public and clinical role of the bioethicist: a figure able to promote dialogue between the world of medicine and the community, and to face ethical dilemmas even in emergent clinical settings.","J Clin Ethics","Nicoli, Federico","Gasparetto, Alessandra","32213700"],"abstract":["The COVID-19 virus is severely testing the Italian healthcare system, as the requests for intensive treatment are greater than the real capacity of the system to receive patients. Given this emergency situation, it follows that citizens are limited in their freedom of movement in order to limit infection, and that in hospitals a significant number of critical situations must be faced. This brief contribution aims to offer a reflection on the public and clinical role of the bioethicist: a figure able to promote dialogue between the world of medicine and the community, and to face ethical dilemmas even in emergent clinical settings."],"journal":"J Clin Ethics","authors":["Nicoli, Federico","Gasparetto, Alessandra"],"date":"2020-03-28T11:00:00Z","year":2020,"_id":"32213700","week":"202013|Mar 23 - Mar 29","source":"PubMed","locations":["Italy","Italian"],"countries":["Italy"],"countries_codes":["ITA|Italy"],"weight":0,"_version_":1662445896488452096,"score":41.15031}]}